Orbit Health
Orbit Health is a digital health company focused on providing personalized care solutions for Parkinson's disease. Their core product, Neptune, is an AI-enabled medical device that utilizes smartwatch sensor data to generate objective insights into Parkinson's motor symptoms and treatment responses. This allows for the personalization of care and improves the dialogue between patients and physicians. Neptune Care is a companion app for patients, offering self-monitoring and learning capabilities, while Neptune is designed for healthcare professionals. The company's vision is to enable early intervention and cost-effective management of Parkinson's, empowering patients to live their best lives.
Orbit Health
Orbit Health is a digital health company focused on providing personalized care solutions for Parkinson's disease. Their core product, Neptune, is an AI-enabled medical device that utilizes smartwatch sensor data to generate objective insights into Parkinson's motor symptoms and treatment responses. This allows for the personalization of care and improves the dialogue between patients and physicians. Neptune Care is a companion app for patients, offering self-monitoring and learning capabilities, while Neptune is designed for healthcare professionals. The company's vision is to enable early intervention and cost-effective management of Parkinson's, empowering patients to live their best lives.
TL;DR
What they do: AI-enabled smartwatch platform (Neptune) and patient app (Neptune Care) for monitoring and personalizing Parkinson's treatment
Headquarters: Munich, Germany
Founders / Leadership: Patty Lee (CEO & co‑founder), Dr. Franz MJ Pfister (co‑founder)
Employees (approx.): 17
Known funding: Seed and grant support (~€4M reported); latest disclosed event Jul 12, 2022
Company Overview
Problem Domain
Parkinson's disease monitoring and chronic care personalization
Industry
Digital health / Medtech
Funding Track Record
Most recent disclosed funding event listed as a Non-equity Assistance round
≈€1,000,000
Seed round reported at ~€4M total with a €1M investment from MedTech Entrepreneurs
≈€1,500,000
Selected for EIT Health Wild Card programme with up to €1.5M support
Received funding/support from the BioInnovation Institute (Creation House)
Investor Signal
“Supported by EIT Health, MedTech Entrepreneurs, BioInnovation Institute, and PharmStars”